U.S. Electrical Stock News

If you are wondering whether Viatris shares still offer value at around US$14.36, you are not alone; many investors are asking the same question right now. The stock has posted returns of 10.7% over 7 days, 16.1% over 30 days, 15.2% year to date, 37.8% over 1 year, 38.2% over 3 years and a 4.5% decline over 5 years, which has drawn attention to how the market is currently pricing the business. Recent news flow around Viatris has focused on its positioning within the pharmaceuticals and...

Teradyne’s FY 2025 Earnings Snapshot Teradyne (TER) has wrapped up FY 2025 with fourth quarter revenue of US$1.1 billion and basic EPS of US$1.64, setting the tone for how investors assess the latest move in profitability. The company has seen quarterly revenue move from US$752.9 million in Q4 2024 to US$1.1 billion in Q4 2025, while basic EPS shifted from US$0.90 to US$1.64 over the same period, providing a clear view of how the top and bottom line have tracked together. With a trailing 12...

ZipRecruiter, Inc. ( NYSE:ZIP ) shareholders that were waiting for something to happen have been dealt a blow with a...

Key Insights Institutions' substantial holdings in Treace Medical Concepts implies that they have significant influence...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

The board of Reynolds Consumer Products Inc. ( NASDAQ:REYN ) has announced that it will pay a dividend on the 27th of...

Aftermath Silver Ltd. recently appointed mining engineer Danny Keating as Chief Operating Officer, while Michael Parker moved into a Technical Director role overseeing the Peruvian and Chilean projects. The reshaped leadership team comes as the Berenguela project enters a critical technical evaluation and de-risking phase, potentially sharpening the company’s project execution capabilities. Next, we’ll explore how this leadership shift, particularly Keating’s mine development background, may...

Key Insights Given the large stake in the stock by institutions, Ambarella's stock price might be vulnerable to their...

Scholar Rock Holding's Chief Scientific Officer has executed multiple insider share sales under a pre-arranged 10b5-1 trading plan. The transactions come as the company readies apitegromab, its muscle-targeted treatment, for potential launch in the U.S. and Europe pending regulatory approvals. The timing links leadership share activity with a period of important commercialization preparations for the company. Scholar Rock Holding (NasdaqGS:SRRK) is drawing fresh attention as insider trading...

As the United States stock market kicks off February with a strong performance, marked by significant gains in major indices like the Dow Jones Industrial Average and the S&P 500, investors are keenly observing opportunities amidst fluctuating economic signals. In this vibrant market environment, identifying undervalued stocks can be particularly appealing as they offer potential value when trading below their intrinsic worth.

As February begins, major U.S. stock indexes have shown a strong start with the Dow Jones Industrial Average gaining 515 points and the S&P 500 nearing record highs, indicating a positive market momentum. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often reflect confidence from those closest to the business in its potential for future success.

As February 2026 begins, U.S. stock markets have shown strength, with major indexes like the Dow Jones and S&P 500 posting notable gains. In this context of market optimism and economic developments, investors are exploring opportunities across various sectors. Penny stocks, despite their somewhat outdated moniker, remain relevant as they often represent smaller or newer companies that can offer unique growth potential at lower price points. When backed by strong financials and solid...

As February 2026 begins, U.S. stock indexes have shown a strong start to the month, with key indices like the Dow Jones and S&P 500 climbing significantly, reflecting positive market sentiment despite recent economic uncertainties such as delayed jobs data due to a government shutdown. In this dynamic environment, identifying promising small-cap stocks requires careful consideration of factors like market resilience and potential for growth amidst broader economic shifts.

As February begins, major U.S. stock indexes have shown strong performance, with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. In this dynamic market environment, dividend stocks can offer stability and income potential, making them an attractive option for investors seeking reliable returns amidst fluctuating market conditions.

Global Industrial Company ( NYSE:GIC ), might not be a large cap stock, but it saw a double-digit share price rise of...

Element Solutions (NYSE:ESI) has completed its acquisition of Micromax, expanding its specialty chemicals portfolio for advanced electronics applications. The company has amended its credit facilities, adding new term loans and increasing revolving credit capacity to support the transaction and future initiatives. Element Solutions, a specialty chemicals supplier to the electronics and industrial markets, is taking a bigger role in the tech hardware supply chain with the Micromax deal. The...

Some stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss. Anyone who held Sprout...

NXP Semiconductors (NXPI) just wrapped up FY 2025 with Q4 revenue of US$3.3b and basic EPS of US$1.80, anchored by net income of US$455m, setting the stage for how investors read the year as a whole. The company has seen quarterly revenue move from US$3.1b in Q4 2024 to US$3.3b in Q4 2025, alongside quarterly EPS shifting from US$1.95 to US$1.80, which feeds into trailing twelve month EPS of US$8.00 on revenue of US$12.3b. With trailing net income of US$2.0b and a reported net margin that has...

Sangamo Therapeutics recently reported detailed Phase 1/2 STAAR study results for its Fabry disease gene therapy, isaralgagene civaparvovec, and confirmed a rolling Biologics License Application submission to the FDA under the Accelerated Approval pathway, supported by kidney function as an intermediate clinical endpoint. The company paired these clinically promising data and regulatory progress with a roughly US$24.82 million follow-on equity raise and a finance leadership change,...

If you are wondering whether Horace Mann Educators at around US$44.92 still offers value, an important question is how its current price compares with what the business may be worth. The stock has returned 4.7% over the last 7 days, while the 1 year return sits at 21.7% and the 3 year return at 38.6%. A 0.6% decline year to date may suggest that expectations and risk perceptions are changing. Recent coverage has focused on Horace Mann Educators as an insurer serving the education community,...

Key Insights The considerable ownership by private companies in GDEV indicates that they collectively have a greater...

Key Insights The considerable ownership by individual investors in NovaBridge Biosciences indicates that they...

To the annoyance of some shareholders, Nocera, Inc. ( NASDAQ:NCRA ) shares are down a considerable 37% in the last...

Some AZZ Inc. ( NYSE:AZZ ) shareholders may be a little concerned to see that the President, Thomas Ferguson, recently...